Clinical Scorecard: Experience with Partial Sensory Rhizotomy for Recurrent and Therapy-Resistant Trigeminal Neuralgia: Insights from a Single Center
At a Glance
Category
Detail
Condition
Trigeminal Neuralgia (TN), a chronic neuralgic pain syndrome characterized by severe, shock-like facial pain attacks.
Key Mechanisms
Focal demyelination of the trigeminal nerve at the root entry zone, often due to vascular compression; atypical forms linked to multiple sclerosis plaques.
Target Population
Patients with therapy-refractory trigeminal neuralgia, especially those without neurovascular compression or with recurrent symptoms after standard treatments.
Care Setting
Specialized neurosurgical centers with capability for microsurgical exploration and partial sensory rhizotomy.
Key Highlights
TN incidence is approximately 4–5 per 100,000, higher in older adults, with typical unilateral lancinating facial pain triggered by innocuous stimuli.
Standard surgical treatment is microvascular decompression (MVD) when neurovascular conflict is present; percutaneous and radiosurgical options exist but have high recurrence rates.
Partial sensory rhizotomy (PSR) is considered for therapy-refractory TN without vascular compression, though it carries higher complication rates and potential postoperative sensory loss.
Guideline-Based Recommendations
Diagnosis
Clinical diagnosis based on characteristic pain features and triggers.
MRI to identify neurovascular compression or demyelinating plaques, especially in multiple sclerosis patients.
Intraoperative exploration to confirm absence of vascular compression before PSR.
Management
First-line treatment is medical therapy.
Surgical options include MVD if neurovascular conflict is present.
Percutaneous procedures (glycerol injection, thermocoagulation, balloon compression) and radiosurgery as alternatives.
PSR reserved for patients with therapy-refractory TN without neurovascular compression or after failed prior interventions.
Monitoring & Follow-up
Postoperative follow-up including clinical assessment and telephone interviews.
Use of intraoperative neuromonitoring (facial and trigeminal nerve EMG, acoustic evoked potentials) during surgery.
Long-term monitoring for recurrence and sensory complications.
Risks
Recurrence rates after MVD approximately 2% per year; up to 80% after percutaneous procedures.
PSR associated with higher complication rates and postoperative sensory loss.
Patient dissatisfaction may be higher after PSR compared to MVD.
Patient & Prescribing Data
Patients with recurrent or therapy-resistant trigeminal neuralgia who have failed medical and other surgical treatments.
Patients often prefer PSR after detailed counseling about risks and benefits, especially when no neurovascular compression is found intraoperatively.
Clinical Best Practices
Confirm absence of neurovascular compression via MRI and intraoperative inspection before performing PSR.
Use intraoperative neuromonitoring and nerve stimulation to identify motor and sensory fibers precisely.
Tailor the extent of sensory root sectioning according to individual pain distribution to optimize pain relief and minimize sensory loss.
Inform patients thoroughly about the potential for postoperative sensory deficits and variable satisfaction rates with PSR.
Consider PSR primarily in patients who have exhausted other treatment options and explicitly consent to this procedure.
Over two days, specialists across neurology, neurosurgery and related subspecialties came together to discuss advances in stroke care, epilepsy, movement disorders, neurodegenerative disease, neuro-oncology, brain and spine surgery, interventional pain management and emerging technologies.
